Thus, the presented work was aimed at investigating the MVA pathway and its end-products in plasma, liver, and in six different brain regions of a recently developed Fmr1-Δexon 8 rat model of FXS [28,29,30]. This evidence concerns the gene FMR1 and fragile X syndrome.